Large extracellular vesicles from induced pluripotent stem cell-marrow stem cells enhance limb angiogenesis via ERK/MAPK.

Nanomedicine (London, England) Pub Date : 2024-07-14 Epub Date: 2024-07-16 DOI:10.1080/17435889.2024.2363743
Ziyu Huang, Zhengsheng Chen, Teng Ye, Lei Luo, Juntao Zhang, Qing Li, Yang Wang, Bizeng Zhao
{"title":"Large extracellular vesicles from induced pluripotent stem cell-marrow stem cells enhance limb angiogenesis via ERK/MAPK.","authors":"Ziyu Huang, Zhengsheng Chen, Teng Ye, Lei Luo, Juntao Zhang, Qing Li, Yang Wang, Bizeng Zhao","doi":"10.1080/17435889.2024.2363743","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study aims to investigate the effects of large extracellular vesicles (EVs) induced by pluripotent stem cell-derived mesenchymal stem cells on lower limb ischemic disease and explore its potential mechanisms. <b>Materials & methods:</b> The pathology of muscles was accessed by H&E staining and immunofluorescence staining. <i>In vitro</i>, we conducted wound-healing assay, tube formation assay, RT qPCR, ELISA, RNA sequencing and proteomic analysis. <b>Results:</b> iMSCs-lEVs alleviated the injury of ischemic lower limb and promoted the recovery of lower limb function. <i>In vitro</i>, iMSCs-lEVs promoted the proliferation, migration, and angiogenesis of HMEC-1 cells by regulating the ERK/MAPK signing pathway. <b>Conclusion:</b> This study demonstrated that iMSCs-lEVs promoted endothelial cell angiogenesis via the ERK/MAPK signaling pathway, thereby improving function after lower limb ischemic injury.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321421/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2024.2363743","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study aims to investigate the effects of large extracellular vesicles (EVs) induced by pluripotent stem cell-derived mesenchymal stem cells on lower limb ischemic disease and explore its potential mechanisms. Materials & methods: The pathology of muscles was accessed by H&E staining and immunofluorescence staining. In vitro, we conducted wound-healing assay, tube formation assay, RT qPCR, ELISA, RNA sequencing and proteomic analysis. Results: iMSCs-lEVs alleviated the injury of ischemic lower limb and promoted the recovery of lower limb function. In vitro, iMSCs-lEVs promoted the proliferation, migration, and angiogenesis of HMEC-1 cells by regulating the ERK/MAPK signing pathway. Conclusion: This study demonstrated that iMSCs-lEVs promoted endothelial cell angiogenesis via the ERK/MAPK signaling pathway, thereby improving function after lower limb ischemic injury.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
诱导多能干细胞-骨髓干细胞的大细胞外囊泡通过ERK/MAPK促进肢体血管生成。
目的:本研究旨在探讨多能干细胞衍生的间充质干细胞诱导的大细胞外囊泡(EVs)对下肢缺血性疾病的影响及其潜在机制。材料与方法:通过H&E染色和免疫荧光染色观察肌肉的病理变化。在体外,我们进行了伤口愈合试验、管形成试验、RT qPCR、ELISA、RNA测序和蛋白质组分析。结果:iMSCs-lEVs能减轻缺血下肢的损伤,促进下肢功能的恢复。在体外,iMSCs-lEVs 通过调节 ERK/MAPK 信号通路促进 HMEC-1 细胞的增殖、迁移和血管生成。结论本研究表明,iMSCs-lEVs 可通过 ERK/MAPK 信号通路促进内皮细胞血管生成,从而改善下肢缺血性损伤后的功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Amitriptyline nanoparticle repositioning prolongs the anti-allodynic effect of enhanced microglia targeting. Membrane-camouflaged biomimetic nanoplatform with arsenic complex for synergistic reinforcement of liver cancer therapy. Nanoparticle-delivered quercetin exhibits enhanced efficacy in eliminating iron-overloaded senescent chondrocytes. A drug delivery system of HIF-1α siRNA nanoparticles loaded by mesenchymal stem cells on choroidal neovascularization. LC-MS/MS method for simultaneous Doxorubicin and Baicalein estimation: formulation and pharmacokinetic applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1